Peyrin-Biroulet, Laurent
Ylänne, Karoliina http://orcid.org/0000-0003-4808-607X
Sipes, Allyson
Segovia, Michelle http://orcid.org/0000-0003-0877-1021
Gardiner, Sean http://orcid.org/0009-0008-9193-9844
Cappelleri, Joseph C. http://orcid.org/0000-0001-9586-0748
Mulvey, Amy
Panaccione, Remo
Funding for this research was provided by:
Pfizer
Article History
Received: 16 March 2023
Accepted: 31 August 2023
First Online: 4 December 2023
Declarations
:
: Michelle Segovia is an employee of The Medical Affairs Company and a former Postdoctoral Fellow of Rutgers University, which was a paid contractor to Pfizer in connection with the development of this manuscript. Amy Mulvey is an employee of The Harris Poll, which was a paid contractor to Pfizer for related statistical analysis.
: Laurent Peyrin-Biroulet has received consulting fees from AbbVie, Abivax, Adacyte, Alimentiv, Alma Bio Therapeutics, Amgen, Applied Molecular Transport, Arena, Biogen, BMS, Celltrion, CONNECT Biopharm, Cytoki Pharma, Enthera, Ferring, Fresenius Kabi, Galapagos, Genentech, Gilead, Gossamer Bio, GSK, HAC-Pharma, IAG Image Analysis, Index Pharmaceuticals, Inotrem, Janssen, Lilly, Medac, Mopac, Morphic, MSD, Nordic Pharma, Norgine, Novartis, OM Pharma, ONO Pharma, OSE Immunotherapeutics, Pandion Therapeutics, Par’Immune, Pfizer Inc, Prometheus, Protagonist, Roche, Roivant, Samsung, Sandoz, Sanofi, Takeda, Theravance, Thermo Fisher, Tigenix, Tillotts, Vectivbio, Ventyx, Viatris, Vifor, and Ysopia. Karoliina Ylänne was an employee of Sidekick Health, Kopavogur, Iceland, at the time of the analysis and is currently an employee and shareholder of Pfizer Inc; has received lecture fees from IBD ja muut suolistosairaudet Ry (patient association), Pfizer Inc, Takeda, and Tillotts Pharma, and consultancy fees from Pfizer Inc, Sandoz, Sidekick Health, and Takeda. Allyson Sipes has received consultancy fees from Pfizer Inc for work unrelated to this analysis. Amy Mulvey is an employee of The Harris Poll, which was a paid contractor to Pfizer for related statistical analysis. Sean Gardiner and Joseph C. Cappelleri are employees and stockholders of Pfizer Inc. Michelle Segovia is an employee of The Medical Affairs Company and a former Postdoctoral Fellow of Rutgers University, which was a paid contractor to Pfizer in connection with the development of this manuscript. Remo Panaccione has received advisory and/or consulting fees from AbbVie, Abbot, Alimentiv (formerly Robarts), Amgen, Arena Pharmaceuticals, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Celltrion, Cosmos Pharmaceuticals, Eisai, Elan, Eli Lilly, Ferring, Galapagos, Genentech, Gilead, GlaxoSmithKline, Janssen, Merck, Mylan, Oppilan Pandion, Pandion Pharma, Pfizer Inc, Progenity, Protagonist Therapeutics, Roche, Sandoz, Satisfai Health, Schering-Plough, Shire, Sublimity Therapeutics, Takeda Pharmaceuticals, Theravance Biopharma, and UCB.
: Patient recruitment was performed from online market research panels consisting of members who agreed to participate in this type of research. Patients provided their consent before completing the questionnaire and received remuneration (on behalf of the investigators by the sponsor) for their participation in the survey. The survey was non-interventional and was not conducted as a clinical study; therefore, all patients agreed to participate but ethics approval was not required.